Vivo Capital, LLC is a global healthcare investment firm based in Palo Alto, CA, with over 25 years of experience and approximately $5.4 billion in assets under management. They focus on investing in promising private and public healthcare companies, with their Vivo Capital Fund IX and Vivo Opportunity Fund. Their investments range from growth capital and private equity in product-driven companies to venture stage investments in game-changing healthcare technologies.
Vivo Capital's team of experienced partners, including Frank Kung, Edgar G. Engleman, Shan Fu, Hongbo Lu, Jack B. Nielsen, Michael Chang, Mahendra G. Shah, Joseph Siletto, Daisy Xu, David Liu, Kevin Dai, and Hao Dong, bring a wealth of knowledge and expertise to their investment strategies. They have a strong portfolio of investments in the healthcare industry, including recent partnerships with Avistone, Merck KGaA, Darmstadt, Germany, RayzeBio, and Gracell.
Generated from the website